Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Precise coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells. Here we show that p21 WAF1/CIP1, the prototype inhibitor of cyclin-dependent kinases (CDKs), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [53]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Self-citationGorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Creative blocks: cell-cycle checkpoints and feedback controls
Murray, A. W. (1992) · Nature · doi:10.1038/359599a0 · Cited by 663
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Ordering S phase and M phase in the cell cycle
Nurse, P. (1994) · Cell · doi:10.1016/0092-8674(94)90539-8 · Cited by 589
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582
Self-citation
Research works printed but not linked: 8
- Waldman, T., Kinzler, K. W. & Vogelstein, B. Cancer Res. 55, 5187–5190 (1995).
- Gorczyca, W., Gong, J. & Darzynkiewicz, Z. Cancer Res. 53, 1945–1951 (1993).
- Gao, X. et al. Oncogene 11, 1395–1398 (1995).
- El-Deiry, W. A. et al. Cancer Res. 55, 2910–2919 (1995).
- Kung, A. L., Zetterberg, A., Sherwood, S. W. & Schimke, R. T. Cancer Res. 50, 7307–7317 (1990).
- Carder, P. et al. Oncogene 8, 1397–1401 (1993).
- Harvey, M. et al. Oncogene 8, 2457–2467 (1993).
- Morrow, C. S. & Cowan, K. H. in Cancer Medicine (eds Holland, J. F. et al.), 618–631 (Lea & Febiger, Philadelphia, 1993).
Cited by
Items 401–500 of 727
Kobayashi, K., & Tsukamoto, I. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00059-x · Cited by 36
New developments in the multi-site phosphorylation and integration of stress signalling at p53
Meek, D. W. (1998) · International Journal of Radiation Biology · doi:10.1080/095530098141005 · Cited by 38
Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression
Ono, Y., Tamiya, T., Ichikawa, T., Matsumoto, K., Furuta, T., Ohmoto, T., Akiyama, K., Seki, S., Ueki, K., & Louis, D. N. (1997) · Acta Neuropathologica · doi:10.1007/s004010050667 · Cited by 35
p21WAF1/CIP1 Expression in breast cancers: associations with p53 and outcome
Thor, A. D., Liu, S., Moore, D. H., Shi, Q., & Edgerton, S. M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006455526894 · Cited by 35
Sengeløv, L., Horn, T. D., & Steven, K. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050106 · Cited by 35
SMG7 is a critical regulator of p53 stability and function in DNA damage stress response
Luo, H., Cowen, L. E., Yu, G., Jiang, W. G., & Tang, Y. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.42 · Cited by 41
The Emerging Molecular Landscape of Urothelial Carcinoma
Solomon, J. P., & Hansel, D. E. (2016) · Surgical pathology clinics · doi:10.1016/j.path.2016.04.004 · Cited by 34
Jorgensen, T. J., Tian, H., Joseph, I. B. J., Menon, K., & Frost, D. J. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0326-2 · Cited by 34
A role for the perlecan protein core in the activation of the keratinocyte growth factor receptor
Ghiselli, G., Eichstetter, I., & Iozzo, R. V. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590153 · Cited by 35
Wilson, D. W., Lamé, M. W., Dunston, S. K., & Segall, H. J. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8966 · Cited by 35
Sarbia, M., Stahl, M., Hausen, A. Z., Zimmermann, K., Wang, L., Fink, U., Heep, H., Dutkowski, P., Willers, R., Müller, W., et al. (1998) · PubMed · Cited by 38
Hermann, S., Sturm, I., Mrozek, A., Klosterhalfen, B., Hauptmann, S., D�rken, B., & Daniel, P. T. (2001) · International Journal of Cancer · doi:10.1002/ijc.1284 · Cited by 34
Hzf, a p53-Responsive Gene, Regulates Maintenance of the G2 Phase Checkpoint Induced by DNA Damage
Sugimoto, M., Gromley, A., & Sherr, C. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.502-512.2006 · Cited by 35
Nonomura, Y., Kohsaka, H., Nasu, K., Terada, Y., Ikeda, M., & Miyasaka, N. (2001) · International Immunology · doi:10.1093/intimm/13.6.723 · Cited by 35
Transcriptional activation of p21WAF1by PTEN/MMAC1 tumr suppressor
Wu, R., Li, X., & Schönthal, A. H. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007024624967 · Cited by 35
Qureshi, K. N., Griffiths, T. R. L., Robinson, M., Marsh, C., Roberts, J. T., Hall, R. R., Lunec, J., & Neal, D. E. (1999) · PubMed · doi:10.25405/ncl.34593843 · Cited by 34
Khan, S., Chib, R., Shah, B. A., Wani, Z. A., Dhar, N., Mondhe, D. M., Lattoo, S. K., Jain, S. K., Taneja, S. C., & Singh, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.013 · Cited by 35
Mechanisms of resistance to ionizing radiation in rectal cancer
Huerta, S., Gao, X., & Saha, D. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.26 · Cited by 33
p53 Activation in Chronic Radiation-Treated Breast Cancer Cells
Xia, L., Paik, A. S., & Li, J. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0969 · Cited by 41
Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53
Ohiro, Y., Usheva, A., Kobayashi, S., Duffy, S., Nantz, R., Gius, D. R., & Horikoshi, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.322-334.2003 · Cited by 36
The Influence of SV40 Immortalization of Human Fibroblasts on p53-Dependent Radiation Responses
Kohli, M., & Jorgensen, T. J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0389 · Cited by 33
Modiano, J. F., Ritt, M. G., Wojcieszyn, J. W., & Smith, R. (1999) · DNA and Cell Biology · doi:10.1089/104454999315259 · Cited by 33
Oleinik, N. V., & Krupenko, S. A. (2003) · PubMed · Cited by 40
Gerashchenko, B. I., Salmiņa, K., Eglītis, J., Huna, A., Grjunberga, V., & Erenpreisa, J. A. (2016) · Histochemistry and Cell Biology · doi:10.1007/s00418-016-1423-x · Cited by 34
Evidence for the receipt of DNA damage stimuli by PML nuclear domains
Varadaraj, A., Dovey, C. L., Laredj, L. N., Ferguson, B. J., Alexander, C., Lubben, N., Wyllie, A., & Rich, T. (2007) · The Journal of Pathology · doi:10.1002/path.2126 · Cited by 33
Baatout, S., Derradji, H., Jacquet, P., & Mergeay, M. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.15.2.337 · Cited by 32
Cytotoxic and genotoxic effects of cleistanthin B in normal and tumour cells
Chhalliyil, P., Panneerselvam, N., Rajesh, S., & Shanmugam, G. (1996) · Mutagenesis · doi:10.1093/mutage/11.6.553 · Cited by 32
Therapeutic relevance of the protein phosphatase 2A in cancer
Cunningham, C. E., Li, S., Vizeacoumar, F. S., Bhanumathy, K. K., Lee, J. S., Parameswaran, S., Furber, L. A., Abuhussein, O., Paul, J. M., McDonald, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11399 · Cited by 33
Serum p53 antibodies: predictors of survival in small-cell lung cancer?
Murray, P. V., Soussi, T., O'Brien, M. E. R., Smith, I. E., Brossault, S., Norton, A., Ashley, S. E., & Tavassoli, M. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1475 · Cited by 32
Genomic Subtyping in Bladder Cancer
Jalanko, T., de Jong, J. J., Gibb, E. A., Seiler, R., & Black, P. C. (2020) · Current Urology Reports · doi:10.1007/s11934-020-0960-y · Cited by 37
M�ller, A. M., Cronen, C., Kupferwasser, L. I., Oelert, H., M�ller, K.-M., & Kirkpatrick, C. J. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200005)191:1<54::aid-path568>3.0.co;2-y · Cited by 100
Proliferation and DNA Aneuploidy in Mild Dysplasia Imply Early Steps of Cervical Carcinogenesis
Steinbeck, R. G. (1997) · Acta Oncologica · doi:10.3109/02841869709100723 · Cited by 31
Regulation and regulatory parameters of histone modifications
Davie, J., & Chadee, D. N. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<203::aid-jcb25>3.0.co;2-4 · Cited by 125
Li, Y., Mao, Y., Rosal, R. V., Dinnen, R. D., Williams, A. C., Brandt‐Rauf, P. W., & Fine, R. L. (2005) · International Journal of Cancer · doi:10.1002/ijc.20838 · Cited by 34
Malashicheva, A., Kislyakova, T., Aksenov, N., Osipov, K. A., & Pospelov, V. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203736 · Cited by 37
The Role of the Smad3 Protein in Phorbol Ester-induced Promoter Expression
Biggs, J. R., & Kraft, A. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.36987 · Cited by 31
Involvement of p53 and WAF1/CIP1 in γ-Irradiation-Induced Apoptosis of Retinoblastoma Cells
Kondo, Y., Kondo, S., Liu, J., Haqqi, T., Barnett, G. H., & Barna, B. P. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3693 · Cited by 31
Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
Zhang, L., He, Y., Wu, X., Zhao, G., Zhang, K., Yang, C. S., Reiter, R. J., & Zhang, J. (2019) · Cells · doi:10.3390/cells8070745 · Cited by 30
The essential role of p21 in radiation-induced cell cycle arrest of vascular smooth muscle cell
Kim, H.-S., Cho, H., Cho, H.-J., Park, S. J., Park, K. W., Chae, I., Oh, B., Park, Y.-B., & Lee, M.-M. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.06.017 · Cited by 30
Stuschke, M., Sak, A., Wurm, R., Sinn, B. V., Wolf, G., Stüben, G., & Budach, V. (2002) · International Journal of Radiation Biology · doi:10.1080/09553000210148903 · Cited by 30
Anna, J. A. D., Valdez, J. G., Habbersett, R. C., & Crissman, H. A. (1997) · Radiation Research · doi:10.2307/3579611 · Cited by 30
The Role of p53/p21/p16 in DNA-Damage Signaling and DNA Repair
Kulaberoglu, Y., Gündoğdu, R., & Hergovich, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803309-8.00015-x · Cited by 46
p21Waf1/Cip1 Deficiency Stimulates Centriole Overduplication
Duensing, A. U., Ghanem, L. R., Steinman, R. A., Liu, Y., & Duensing, S. M. (2006) · Cell Cycle · doi:10.4161/cc.5.24.3567 · Cited by 32
Courapied, S., Cherier, J., Vigneron, A. M., Troadec, M., Giraud, S., Valo, I., Prigent, C., Gamelin, E. C., Coqueret, O., & Barré, B. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-205 · Cited by 29
O’Nions, J., & Allday, M. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206838 · Cited by 29
IGF-1 activates p21 to inhibit UV-induced cell death
Murray, S. A., Zheng, H., Gu, L., & Xiao, Z. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206327 · Cited by 32
Relationship between Expression of p21WAF1/CIP1 and Radio resistance in Human Gliomas
Kokunai, T., & Tamaki, N. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00795.x · Cited by 29
Playle, L. C., Hicks, D. J., Qualtrough, D., & Paraskeva, C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600492 · Cited by 36
Specific Inhibition of the Nuclear Exporter Exportin-1 Attenuates Kidney Cancer Growth
Wettersten, H. I., Landesman, Y., Friedlander, S., Shacham, S., Kauffman, M. G., & Weiss, R. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113867 · Cited by 28
Vazhappilly, C. G., Hodeify, R. F., Siddiqui, S. S., Laham, A. J., Menon, V., El‐Awady, R., Matar, R., Merheb, M. M., Marton, J., Zouabi, H. A., et al. (2020) · Phytotherapy Research · doi:10.1002/ptr.6970 · Cited by 28
Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells
Vitale, I., Senovilla, L., Galluzzi, L., Criollo, A., Vivet, S., Castedo, M., & Kroemer, G. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6073 · Cited by 34
Nimbalkar, D., Henry, M. K., & Quelle, F. W. (2003) · PubMed · Cited by 28
Functional Loss of p21/Waf-1 in a Case of Benign Canine Multicentric Melanoma
Ritt, M. G., Wojcieszyn, J. W., & Modiano, J. F. (1998) · Veterinary Pathology · doi:10.1177/030098589803500202 · Cited by 28
Induction of glutathione synthetase by 1,10‐phenanthroline
Sun, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00380-3 · Cited by 28
Bartolomeo, S. D., Sano, F. D., Piacentini, M., & Spinedi, A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750532.x · Cited by 28
Activation of DNA damage response signaling in mammalian cells by ionizing radiation
Ghosh, S., & Ghosh, A. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1876853 · Cited by 33
McGrath‐Morrow, S. A., & Stahl, J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00142-7 · Cited by 27
Geller, J. I., Szücs, K. S., Peták, I., Doyle, B. T., & Houghton, J. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0863 · Cited by 27
Apoptosis and its clinical significance for bladder cancer therapy
Kelly, J. D., Williamson, K., Irvine, A. E., Hamilton, P. W., Weir, H. P., Anderson, N. H., Keane, P. F., & Johnston, S. R. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00871.x · Cited by 29
Staversky, R. J., Watkins, R. H., Wright, T. W., Hernady, E., LoMonaco, M. B., D’Angio, C. T., Williams, J. P., Maniscalco, W. M., & O’Reilly, M. A. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64414-8 · Cited by 31
Shin, B. A., Ahn, K. Y., Kook, H. Y., Koh, J. T., Kang, I. C., Lee, H. C., & Kim, K. K. (2001) · PubMed · Cited by 30
Wang, L., Guo, H., Zhan, Y., Feng, C., Huang, S., Han, Y., Zheng, W., & Jiang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15918 · Cited by 26
Sturm, I., Rau, B., Schlag, P. M., Wust, P., Hildebrandt, B., Riess, H. B., Hauptmann, S., Dörken, B., & Daniel, P. T. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-124 · Cited by 28
Kolettas, E., Thomas, C. G., Leneti, E., Skoufos, I., Batsi, C., Sisoula, C., Manos, G., & Evangelou, A. M. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9064-8 · Cited by 26
Galectin-3 regulates p21 stability in human prostate cancer cells
Wang, Y., Balan, V., Kho, D., Hogan, V. A., Nangia‐Makker, P., & Raz, A. (2012) · Oncogene · doi:10.1038/onc.2012.528 · Cited by 28
Balcer‐Kubiczek, E. K., Attarpour, M., Jiang, J., Kennedy, A. S., & Suntharalingam, M. (2006) · Chemotherapy · doi:10.1159/000094869 · Cited by 28
Antisense Oligonucleotides Targeted to the p53 Gene Modulate Liver Regeneration In Vivo
Arora, V., & Iversen, P. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15119-7 · Cited by 27
Mujoo, K., Watanabe, M., Nakamura, J., Khokhar, A. R., & Siddik, Z. H. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0480-4 · Cited by 28
Kielb, S., SHAH, N. L., Rubin, M. A., & Sanda, M. G. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65967-8 · Cited by 26
Zölzer, F. (2000) · International Journal of Radiation Biology · doi:10.1080/095530000138394 · Cited by 26
Which guesstimate is the best guesstimate? Predicting chemotherapeutic outcomes
Lamb, J. R., & Friend, S. H. (1997) · Nature Medicine · doi:10.1038/nm0997-962 · Cited by 26
The antagonistic relationship between apoptosis and polyploidy in development and cancer
Herriage, H. C., Huang, Y., & Calvi, B. R. (2023) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2023.05.009 · Cited by 26
Lee, S.-J., Park, S. S., Kim, W., & Moon, S. (2012) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x12500292 · Cited by 25
Huart, A.-S., MacLaine, N. J., Narayan, V., & Hupp, T. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043391 · Cited by 32
Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review
Grimminger, C., & Danenberg, P. V. (2010) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-010-1369-x · Cited by 25
Gao, Y., Um, C. Y., Fedirko, V., Rutherford, R. E., Seabrook, M. E., Barry, E. L., Baron, J. A., & Bostick, R. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208762 · Cited by 26
Moran, D. M., Gawlak, G., Jayaprakash, M., Mayar, S., & Maki, C. G. (2008) · Oncogene · doi:10.1038/onc.2008.172 · Cited by 26
Involvement of cell cycle control in bleomycin‐induced mutagen sensitivity
Cloos, J. J., Temmink, O. H., Ceelen, M., Snel, M. H. J., Leemans, C. R., & Braakhuis, B. J. M. (2002) · Environmental and Molecular Mutagenesis · doi:10.1002/em.10093 · Cited by 25
Tang, J., Shen, C., & Lu, Y. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9206-7 · Cited by 25
Sequence of lethal events in HeLa cells exposed to the G2 blocking cytolethal distending toxin
de Rycke, J., Sert, V., Comayras, C., & Tasca, C. (2000) · European Journal of Cell Biology · doi:10.1078/s0171-9335(04)70022-9 · Cited by 26
Cloning and characterization of aDictyostelium gene encoding a small GTPase of the Rab11 family
Dragoi, I. A., & O’Halloran, T. J. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19980701)70:1<22::aid-jcb3>3.0.co;2-5 · Cited by 4
Soh, J., Lee, Y., & Weinstein, I. B. (2003) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2003.01087.x · Cited by 25
Ito, A., Koma, Y.-I., Watabe, K., Nagano, T., Endo, Y., Nojima, H., & Kitamura, Y. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63800-x · Cited by 24
“This type of defect is known as the “uncoupling” of the S and M phases.(32,33) However, when BL6 and F10 cells are grown and irradiated in vivo, the BL6 cell-cycle checkpoint becomes more aberrant compared to F10 because the BL6 cells display a high degree of polyploidy that is evident for a longer period and the rate…”
BackgroundRadiosensitization of HT‐29 cells and xenografts by the nitric oxide donor DETANONOate
Gao, X., Saha, D., Kapur, P., Anthony, T., Livingston, E. H., & Huerta, S. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21318 · Cited by 25
Müller-Decker, K., Kopp-Schneider, A., Marks, F., Seibert, K., & Fürstenberger, G. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199809)23:1<36::aid-mc5>3.0.co;2-f · Cited by 109
Cao, W., Chi, W., Wang, J., Tang, J., & Lu, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.188 · Cited by 27
Huang, Y. K., Chan, A. M.-L., Liu, Y., Wang, X., & Holbrook, N. J. (1997) · APOPTOSIS · doi:10.1023/a:1026420616484 · Cited by 24
Murphy, M. R., Ramadei, A., Doymaz, A., Varriano, S., Natelson, D. M., Yu, A., Aktas, S., Mazzeo, M., Mazzeo, M., Zakusilo, G., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad899 · Cited by 24
Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53
Mann, K., & Hainaut, P. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208563 · Cited by 24
Cyclin A–associated kinase activity is needed for paclitaxel sensitivity
Takahashi, T., Yamasaki, F., Sudo, T., Itamochi, H., Adachi, S., Tamamori‐Adachi, M., & Ueno, N. T. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0282 · Cited by 23
(1997) · Trends in Genetics · doi:10.1016/0168-9525(97)90029-9 · Cited by 148
Lin, Y., & Wang, F.-F. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.10.017 · Cited by 28
8-Cl-Adenosine-Induced Inhibition of Colorectal Cancer Growth In Vitro and In Vivo
Carlson, C. C., Chinery, R., Burnham, L. L., & Dransfield, D. T. (2000) · Neoplasia · doi:10.1038/sj.neo.7900106 · Cited by 23
Côté, R. J., Mitra, A. P., & Amin, M. B. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3966-2.00031-x · Cited by 26
The inherited susceptibility to cancer
Guilford, P. (2000) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000721 · Cited by 28
Wang, Z., Wang, S., Fisher, P. B., Dent, P., & Grant, S. (2000) · Differentiation · doi:10.1046/j.1432-0436.2000.066001001.x · Cited by 23
Overcoming of Radioresistance in Human Gliomas by p21WAF1/CIP1 Antisense Oligonucleotide
Kokunai, T., Urui, S., Tomita, H., & Tamaki, N. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010645205169 · Cited by 23
p53 Checkpoint-Defective Cells Are Sensitive to X Rays, but Not Hypoxia
Denko, N. C., Green, S., Edwards, D., & Giaccia, A. J. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4928 · Cited by 26
Rüller, S., Stahl, C., Köhler, G., Eickhoff, B., Breder, J., Schlaak, M. S., & van der Bosch, J. (1999) · PubMed · Cited by 23
Hemmati, P., Normand, G., Gillissen, B. F., Wendt, J., Dörken, B., & Daniel, P. T. (2008) · Oncogene · doi:10.1038/onc.2008.193 · Cited by 26
Metadata
- Authors
- Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1996-06
- Volume
- 381
- Issue
- 6584
- Pages
- 713-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2008117987
- Cited by
- 728
- References
- 28
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 12 · 2017: 5 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 10 · 2012: 18
- FWCI
- 32.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cell cycle checkpoints, cyclin-dependent kinases, DNA damage response, polyploidy, apoptosis, anticancer agents, cell cycle coordination
- MeSH terms
- Antineoplastic Agents, Camptothecin, DNA Damage, Doxorubicin, Enzyme Inhibitors, Etoposide, Fluorescent Dyes, Gamma Rays, Bisbenzimidazole, Humans, Mitosis, Tumor Cells, Cultured, S Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.